| Name: | MEDISCA INC. |
| Jurisdiction: | New York |
| Legal type: | DOMESTIC BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 24 Jun 1992 (33 years ago) |
| Entity Number: | 1646528 |
| ZIP code: | 12901 |
| County: | Clinton |
| Place of Formation: | New York |
| Principal Address: | 4115 CLAUDE HENRI GRIGNON, ST LAURENT QUEBEC, Canada |
| Address: | 661 ROUTE 3, UNIT C, PLATTSBURGH, NY, United States, 12901 |
Shares Details
Shares issued 1000
Share Par Value 0
Type NO PAR VALUE
| Type | Company Name | Company Number | State |
|---|---|---|---|
| Headquarter of | MEDISCA INC., Alaska | 10273340 | Alaska |
| Headquarter of | MEDISCA INC., FLORIDA | F12000000155 | FLORIDA |
| Headquarter of | MEDISCA INC., Alabama | 000-008-407 | Alabama |
| Unique Entity ID | Expiration Date | Physical Address | Mailing Address | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GBVSZUB6S156 | 2024-06-22 | 661 STATE ROUTE 3, UNIT C, PLATTSBURGH, NY, 12901, 6531, USA | 661 RT.3, UNIT C, PLATTSBURGH, NY, 12901, 6531, USA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| URL | http://www.medisca.com |
| Congressional District | 21 |
| State/Country of Incorporation | NY, USA |
| Activation Date | 2023-06-27 |
| Initial Registration Date | 2010-07-27 |
| Entity Start Date | 1992-06-24 |
| Fiscal Year End Close Date | May 31 |
Service Classifications
| NAICS Codes | 339113, 424210, 424990, 561910 |
| Product and Service Codes | 6515, 6520, 6550, 6640 |
Points of Contacts
| Electronic Business | |
|---|---|
| Title | PRIMARY POC |
| Name | VANESSA VERNI |
| Role | DIRECTOR OF REGULATORY AFFAIRS |
| Address | 661 STATE RTE 3 UNIT C, PLATTSBURGH, NY, 12901, 6531, USA |
| Title | ALTERNATE POC |
| Name | VANESSA VERNI |
| Role | DIRECTOR OF REGULATORY AFFAIRS |
| Address | 6090 BOUL HENRI-BOURASSA O, SAINT-LAURENT, QC, H4R 3A6-0229, CAN |
| Government Business | |
|---|---|
| Title | PRIMARY POC |
| Name | JUMANA RAMADAN |
| Role | ASSISTANT |
| Address | 661 STATE RTE 3 UNIT C, PLATTSBURGH, NY, 12901, 6531, USA |
| Title | ALTERNATE POC |
| Name | GRAEME BOZZARD |
| Role | BUSINESS DEVELOPMENT MANAGER |
| Address | 6090 BOUL HENRI-BOURASSA O, SAINT-LAURENT, QC, H4R 3A6, CAN |
| Past Performance | |
|---|---|
| Title | PRIMARY POC |
| Name | PHILIPA ATTA |
| Role | REGULATORY AFFAIRS PROJECT COORDINATOR |
| Address | 6090 BOUL HENRI-BOURASSA O, SAINT-LAURENT, QC, H4R 3A6-0229, CAN |
| Title | ALTERNATE POC |
| Name | VANESSA VERNI |
| Role | DIRECTOR OF REGULATORY AND LEGAL AFFAIRS |
| Address | 6090 BOUL HENRI-BOURASSA O, SAINT-LAURENT, QC, H4R 3A6-0229, CAN |
| CAGE number | Status | Type | Established | CAGE Update Date | CAGE Expiration | SAM Expiration | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62W55 | Active | Non-Manufacturer | 2010-07-27 | 2024-08-12 | 2029-08-12 | 2025-08-08 | |||||||||||||
|
|||||||||||||||||||
| POC | PHILIPA ATTA |
| Fax | +1 518-561-0078 |
| Address | 661 STATE ROUTE 3, PLATTSBURGH, NY, 12901 6531, UNITED STATES |
Ownership of Offeror Information
| Highest Level Owner | Information not Available |
|---|
| Immediate Level Owner | Information not Available |
|---|
| List of Offerors (0) | Information not Available |
|---|
| LEI number | Registered As | Jurisdiction Of Formation | General Category | Entity Status | Entity created at | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5493002M8J6761PJUM82 | 1646528 | US-NY | GENERAL | ACTIVE | 1992-06-24 | |||||||||||||||||||
|
||||||||||||||||||||||||
| Legal | 661 ROUTE 3, UNIT C, PLATTSBURGH, US-NY, US, 12901 |
| Headquarters | 661 ROUTE 3, UNIT C, PLATTSBURGH, US-NY, US, 12901 |
Registration details
| Registration Date | 2019-03-26 |
| Last Update | 2024-01-29 |
| Status | ISSUED |
| Next Renewal | 2025-02-02 |
| LEI Issuer | 5493001KJTIIGC8Y1R12 |
| Corroboration Level | FULLY_CORROBORATED |
| Data Validated As | 1646528 |
| Plan Name | Plan Year | EIN/PN | Received | Sponsor | Total number of participants | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDISCA INC. HEALTH AND WELFARE BENEFIT PLAN | 2018 | 141752583 | 2019-11-22 | MEDISCA INC. | 104 | |||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
| Active participants | 104 |
| File | View Page |
| Three-digit plan number (PN) | 501 |
| Effective date of plan | 2015-06-01 |
| Business code | 446110 |
| Sponsor’s telephone number | 5143337811 |
| Plan sponsor’s mailing address | 661 ROUTE 3 UNIT C, PLATTSBURGH, NY, 129016531 |
| Plan sponsor’s address | 661 ROUTE 3 UNIT C, PLATTSBURGH, NY, 129016531 |
Plan administrator’s name and address
| Administrator’s EIN | 141752583 |
| Plan administrator’s name | JENNIFER PINSKY |
| Plan administrator’s address | 661 ROUTE 3 UNIT C, PLATTSBURGH, NY, 129016531 |
| Administrator’s telephone number | 5143337811 |
Number of participants as of the end of the plan year
| Active participants | 96 |
| Retired or separated participants receiving benefits | 5 |
| Three-digit plan number (PN) | 501 |
| Effective date of plan | 2015-06-01 |
| Business code | 446110 |
| Sponsor’s telephone number | 5143337811 |
| Plan sponsor’s mailing address | 661 ROUTE 3 UNIT C, PLATTSBURGH, NY, 129016531 |
| Plan sponsor’s address | 661 ROUTE 3 UNIT C, PLATTSBURGH, NY, 129016531 |
Plan administrator’s name and address
| Administrator’s EIN | 141752583 |
| Plan administrator’s name | JENNIFER PINSKY |
| Plan administrator’s address | 661 ROUTE 3 UNIT C, PLATTSBURGH, NY, 129016531 |
| Administrator’s telephone number | 5143337811 |
Number of participants as of the end of the plan year
| Active participants | 96 |
| Retired or separated participants receiving benefits | 5 |
| File | View Page |
| Three-digit plan number (PN) | 001 |
| Effective date of plan | 2014-01-01 |
| Business code | 325410 |
| Sponsor’s telephone number | 8009321039 |
| Plan sponsor’s address | 661 ROUTE 3, UNIT C, PLATTSBURGH, NY, 12901 |
| File | View Page |
| Three-digit plan number (PN) | 001 |
| Effective date of plan | 2014-01-01 |
| Business code | 325410 |
| Sponsor’s telephone number | 8009321039 |
| Plan sponsor’s address | 661 ROUTE 3, UNIT C, PLATTSBURGH, NY, 12901 |
| Name | Role | Address |
|---|---|---|
| MEDISCA INC. | DOS Process Agent | 661 ROUTE 3, UNIT C, PLATTSBURGH, NY, United States, 12901 |
| Name | Role | Address |
|---|---|---|
| ANTONIO DOS SANTOS | Chief Executive Officer | 4115 CLAUDE HENRI GRIGNON, ST LAURENT QUEBEC, Canada |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-08-21 | 2024-08-21 | Address | 4115 CLAUDE HENRI GRIGNON, ST LAURENT QUEBEC, CAN (Type of address: Chief Executive Officer) |
| 2024-08-21 | 2025-03-06 | Shares | Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0 |
| 2024-01-05 | 2024-08-21 | Shares | Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0 |
| 2023-06-13 | 2024-08-21 | Address | 661 ROUTE 3, UNIT C, PLATTSBURGH, NY, 12901, USA (Type of address: Service of Process) |
| 2023-06-13 | 2024-08-21 | Address | 4115 CLAUDE HENRI GRIGNON, ST LAURENT QUEBEC, CAN (Type of address: Chief Executive Officer) |
| 2023-06-13 | 2024-01-05 | Shares | Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0 |
| 2023-06-13 | 2023-06-13 | Address | 4115 CLAUDE HENRI GRIGNON, ST LAURENT QUEBEC, CAN (Type of address: Chief Executive Officer) |
| 2022-09-30 | 2023-06-13 | Shares | Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0 |
| 2008-07-11 | 2023-06-13 | Address | 4115 CLAUDE HENRI GRIGNON, ST LAURENT QUEBEC, CAN (Type of address: Chief Executive Officer) |
| 2000-07-19 | 2022-09-30 | Shares | Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0 |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 240821002120 | 2024-08-21 | BIENNIAL STATEMENT | 2024-08-21 |
| 230613003244 | 2023-06-13 | BIENNIAL STATEMENT | 2022-06-01 |
| 200602060157 | 2020-06-02 | BIENNIAL STATEMENT | 2020-06-01 |
| 180605007185 | 2018-06-05 | BIENNIAL STATEMENT | 2018-06-01 |
| 140707006321 | 2014-07-07 | BIENNIAL STATEMENT | 2014-06-01 |
| 120817002552 | 2012-08-17 | BIENNIAL STATEMENT | 2012-06-01 |
| 100707002476 | 2010-07-07 | BIENNIAL STATEMENT | 2010-06-01 |
| 080711002308 | 2008-07-11 | BIENNIAL STATEMENT | 2008-06-01 |
| 060614002120 | 2006-06-14 | BIENNIAL STATEMENT | 2006-06-01 |
| 040708002799 | 2004-07-08 | BIENNIAL STATEMENT | 2004-06-01 |
| Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PURCHASE ORDER | AWARD | 75N95024P00433 | 2024-08-22 | 2025-08-21 | 2025-08-21 | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Obligated Amount | 16030.30 |
| Current Award Amount | 16030.30 |
| Potential Award Amount | 16030.30 |
Description
| Title | CAPUSLE FILLING MACHINE, TORPAC PROFILLER 3700 COMBO B (4), 7997-01 AND PROFILLER 1100 COMBO B (4), 7456-01 |
| NAICS Code | 339113: SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING |
| Product and Service Codes | 6640: LABORATORY EQUIPMENT AND SUPPLIES |
Recipient Details
| Recipient | MEDISCA INC. |
| UEI | GBVSZUB6S156 |
| Recipient Address | UNITED STATES, 661 STATE ROUTE 3, UNIT C, PLATTSBURGH, CLINTON, NEW YORK, 129016531 |
| Inspection Nr | Report ID | Date Opened | Site Address | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 340808260 | 0213100 | 2015-07-21 | 661 ROUTE 3, PLATTSBURGH, NY, 12901 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Type | Inspection |
| Activity Nr | 959018 |
| Health | Yes |
| Inspection Type | Complaint |
| Scope | Partial |
| Safety/Health | Health |
| Close Conference | 2014-06-06 |
| Case Closed | 2015-03-13 |
Related Activity
| Type | Complaint |
| Activity Nr | 870988 |
| Health | Yes |
Violation Items
| Citation ID | 01001 |
| Citaton Type | Serious |
| Standard Cited | 5A0001 |
| Issuance Date | 2014-08-06 |
| Abatement Due Date | 2015-02-22 |
| Current Penalty | 5250.0 |
| Initial Penalty | 7000.0 |
| Final Order | 2014-08-29 |
| Nr Instances | 1 |
| Nr Exposed | 16 |
| Gravity | 10 |
| FTA Current Penalty | 0.0 |
| Citation text line | OSH ACT of 1970 Section (5)(a)(1): Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The employer did not furnish employment and a place of employment which were free from recognized hazards that were causing for likely to cause death or serious physical harm to employees in that employees were exposed to active pharmaceutical ingredients (APIs) which can cause illness, genetic defects and death: a) Medisca Laboratories - On or about April 16, 2014, the employer did not categorize the highly potent API to determine and provide adequate closed system containment of the powders based on the hazards and recommended exposure limits. Employees were exposed to highly potent API while repackaging the powders by scooping the material in kilogram quantities from large containers to smaller containers via open handling method. Accumulated API Powder was observed on the tables, floors, open face HEPA filtering systems, equipment, the employees? personal protective equipment, and on the exterior of the containers. The highly potent API included but was not limited to: - Lab 2C ?Diazepam. Hazards for Diazepam include but are not limited to, teratogen (damaging unborn child), mutagen (causing genetic defects), fatal if swallowed, contact with skin is toxic, and central nervous system depression. - Lab 3 ? Ketoprofen. Hazards for Ketoprofen include but are not limited to, possible teratogen (damaging unborn child) and possible mutagen (causing genetic defects). - Lab 2 ? Ketamine Hydrochloride. Hazards for Ketamine Hydrochloride include but are not limited to, possible circulatory and central nervous system damage. - Lab 3 ? Hydroquinone. Hazards for Hydroquinone include but are not limited to, possible carcinogen, possible mutagen (causing genetic defects), and sensitizer. 1) Develop and implement an active pharmaceutical powder exposure control program such as the Safebridge system, ?Occupational Health Toxicity/Potency Categorization and Handling Practices?. The program should include but not be limited to the following: Feasible abatement includes but is not limited to: 1) Develop and implement an active pharmaceutical powder exposure control program such as the Safebridge system, ?Occupational Health Toxicity/Potency Categorization and Handling Practices?. The program should include but not be limited to the following: Evaluation of API toxicity Evaluate acceptable occupational exposure levels. Evaluation of occupational exposure levels should include any regulatory established levels (OSHA), non-regulatory agencies (NIOSH), non-government professional organizations (ACGIH), and API manufacturer set levels. When there is limited or no data on occupational exposure levels for APIs, develop in-house occupational exposure limit ranges referred to as Occupational Exposure Bands (OEBs) or Control Bands. Assigning an OEB is the assignment of a compound to a hazard category that represents a range of occupational exposures and designates the correlating safe handling methods to contain the API to include engineering controls, administrative controls, and personal protective equipment. Several methods for setting OEBs are established in pharmaceutical focused journals. 2) Provide localized containment and ventilation such as a vented balance safety enclosure, isolator, or bulk powder handling enclosure to adequately capture contaminant and minimize employee exposure to below acceptable occupational exposure levels. 3) Conduct breathing zone and area air monitoring to ensure that the engineering controls contain the API to below the acceptable occupational exposure levels. 4) Develop and implement specific procedures for the handling of APIs with the engineering controls. 5) Train employees on methods to avoid unnecessary API exposure to include: Donning and doffing personal protective equipment Emergency spill mitigation techniques Decontamination procedures Waste handling Product transfer in and out of containment procedures Product transfer between container procedures 6) Establish a medical surveillance program to evaluate potential employee exposure to API. The program should include questionnaires, physical exams, baseline and frequent laboratory testing to determine potential exposure and symptoms. |
| Citation ID | 01002 |
| Citaton Type | Serious |
| Standard Cited | 19100106 E02 II B 2 |
| Issuance Date | 2014-08-06 |
| Abatement Due Date | 2014-08-08 |
| Current Penalty | 2250.0 |
| Initial Penalty | 3000.0 |
| Final Order | 2014-08-29 |
| Nr Instances | 1 |
| Nr Exposed | 66 |
| Gravity | 1 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.106(e)(2)(ii)(b)(2): The quantity of Category 2, 3 or 4 flammable liquid located outside of an inside storage room or storage cabinet in a building or in any one fire area of a building exceeded 120 gallons: a) Chemical Storage Area - On and prior to February 10, 2014, the quantity of category 2 flammable liquids located outside of flammable storage cabinets was approximately 160 gallons in a room that did not meet the requirements of a flammable storage room. The chemicals in storage included, but were not limited to, Isopropyl Alcohol and Ethyl Alcohol. |
| Citation ID | 01003 |
| Citaton Type | Serious |
| Standard Cited | 19100134 D01 III |
| Issuance Date | 2014-08-06 |
| Abatement Due Date | 2014-09-19 |
| Current Penalty | 5250.0 |
| Initial Penalty | 7000.0 |
| Final Order | 2014-08-29 |
| Nr Instances | 1 |
| Nr Exposed | 16 |
| Gravity | 10 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.134(d)(1)(iii): The employer did not identify and evaluate the respiratory hazard(s) in the workplace, including a reasonable estimate of employee exposures to respiratory hazard(s) and an identification of the contaminant's chemical state and physical form: a) Medisca Labs - On and prior to April 16, 2014, for the repackaging of active pharmaceutical ingredients including, but not limited to, Hydroquinone (potential carcinogen), Diazepam (teratogen), Estradiol (carcinogen), Chloramphenicol (potential carcinogen), Ketoprofen (possible teratogen and possible mutagenic), and Ketamine HCL (causes central nervous system damage). The employer failed to evaluate the respiratory hazards involved with these activities. |
| Citation ID | 01006A |
| Citaton Type | Serious |
| Standard Cited | 19101200 G02 IV |
| Issuance Date | 2014-08-06 |
| Abatement Due Date | 2014-08-28 |
| Current Penalty | 5250.0 |
| Initial Penalty | 7000.0 |
| Final Order | 2014-08-29 |
| Nr Instances | 2 |
| Nr Exposed | 66 |
| Gravity | 10 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.1200(g)(2)(iv): Each material safety data sheet (MSDS) for hazardous chemicals did not contain at least the health hazards of the hazardous chemical, including signs and symptoms of exposure, and any medical conditions which are generally recognized as being aggravated by exposure to the chemical: a) On and prior to April 16, 2014, the Medisca Chloramphenicol MSDS did not contain health hazards, including but not limited to, genotoxic (cause genetic defects). This health hazard is listed on the Report on Carcinogens, Twelfth Edition of the National Toxicology Program. b) On and prior to April 16, 2014, the Medisca Hydroquinone MSDS did not contain health hazards, including but not limited to, mutagen (may cause genetic defects) and teratogen (may cause birth defects to a fetus). These health hazards are listed on the original manufacturer MSDS (Bulk Medicines & Pharmaceuticals). |
| Citation ID | 01006B |
| Citaton Type | Serious |
| Standard Cited | 19101200 G02 VI |
| Issuance Date | 2014-08-06 |
| Abatement Due Date | 2014-08-28 |
| Current Penalty | 0.0 |
| Initial Penalty | 7000.0 |
| Final Order | 2014-08-29 |
| Nr Instances | 3 |
| Nr Exposed | 66 |
| Gravity | 10 |
| FTA Current Penalty | 0.0 |
| Citation text line | 29 CFR 1910.1200(g)(2)(vi): Material safety data sheets (MSDS) for hazardous chemicals did not contain at least the OSHA permissible exposure limit, ACGIH Threshold Limit Value, and any other exposure limit used or recommended by the chemical manufacturer, importer, or employer preparing the material safety data sheet: a) On and prior to April 16, 2014, the Medisca Diazepam MSDS did not contain an occupational exposure limit (listed as National/European) of 0.02mg/m3 listed on the original manufacturer MSDS (Cambrex Profarmaco Milano). Hazards of Diazepam include, but are not limited to, teratogen (may cause birth defects to a fetus). b) On and prior to April 16, 2014, the Medisca Chloramphenicol MSDS did not contain an occupational exposure limit (listed as AIHA WEEL ) of 0.5mg/m3 listed on the original manufacturer MSDS (Yangzhou Pharmaceutical). Hazards of Chloramphenicol include, but are not limited to, may cause cancer. c) On and prior to April 16, 2014, the Medisca Hydroquinone MSDS did not contain an occupational exposure limit (listed as WEL Long-term value) of 0.5mg/m3 listed on the original manufacturer MSDS (Bulk Medicines & Pharmaceuticals). Additionally, the ACGIH TLV of 2 mg/m3, NIOSH REL 2mg/m3, NIOSH IDLH 50mg/m3 and OSHA PEL 2mg/m3 were not listed on the Medisca MSDS. Hazards of Hydroquinone include, but are not limited to, mutagen (may cause genetic defects) and teratogen (may cause birth defects to a fetus). |
| Inspection Type | Complaint |
| Scope | Partial |
| Safety/Health | Safety |
| Close Conference | 2007-08-30 |
| Case Closed | 2007-12-05 |
Related Activity
| Type | Complaint |
| Activity Nr | 205324031 |
| Safety | Yes |
| Health | Yes |
Violation Items
| Citation ID | 01001 |
| Citaton Type | Serious |
| Standard Cited | 5A0001 |
| Issuance Date | 2007-10-18 |
| Abatement Due Date | 2007-10-26 |
| Current Penalty | 1750.0 |
| Initial Penalty | 1750.0 |
| Nr Instances | 1 |
| Nr Exposed | 5 |
| Gravity | 03 |
| Hazard | CHEMICAL |
| Citation ID | 01002 |
| Citaton Type | Serious |
| Standard Cited | 19100023 C01 |
| Issuance Date | 2007-10-18 |
| Abatement Due Date | 2007-10-26 |
| Current Penalty | 1400.0 |
| Initial Penalty | 1400.0 |
| Nr Instances | 1 |
| Nr Exposed | 2 |
| Gravity | 02 |
| Citation ID | 01003 |
| Citaton Type | Serious |
| Standard Cited | 19100151 C |
| Issuance Date | 2007-10-18 |
| Abatement Due Date | 2007-10-26 |
| Current Penalty | 1750.0 |
| Initial Penalty | 1750.0 |
| Nr Instances | 2 |
| Nr Exposed | 5 |
| Gravity | 03 |
| Citation ID | 02001 |
| Citaton Type | Other |
| Standard Cited | 19040029 B01 |
| Issuance Date | 2007-10-18 |
| Abatement Due Date | 2007-10-26 |
| Nr Instances | 1 |
| Nr Exposed | 45 |
| Gravity | 00 |
| Citation ID | 02002 |
| Citaton Type | Other |
| Standard Cited | 19100022 D01 |
| Issuance Date | 2007-10-18 |
| Abatement Due Date | 2007-10-26 |
| Nr Instances | 2 |
| Nr Exposed | 5 |
| Gravity | 01 |
| Loan Number | Loan Funded Date | SBA Origination Office Code | Loan Delivery Method | Borrower Street Address | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2916667210 | 2020-04-16 | 0248 | PPP | 661 Route 3, PLATTSBURGH, NY, 12901 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Status | User ID | Name of Firm | Trade Name | UEI | Address | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Active | P1288662 | MEDISCA INC. | - | GBVSZUB6S156 | 661 STATE ROUTE 3, UNIT C, PLATTSBURGH, NY, 12901-6531 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Name | Antonio Dos Santos |
| Role | President |
SBA Federal Certifications
| HUBZone Certified | No |
| Women Owned Certified | No |
| Women Owned Pending | No |
| Economically Disadvantaged Women Owned Certified | No |
| Economically Disadvantaged Women Owned Pending | No |
| Veteran-Owned Small Business Certified | No |
| Veteran-Owned Small Business Joint Venture | No |
| Service-Disabled Veteran-Owned Small Business Certified | No |
| Service-Disabled Veteran-Owned Small Business Joint Venture | No |
Bonding Levels
| Description | Construction Bonding Level (per contract) |
| Level | $0 |
| Description | Construction Bonding Level (aggregate) |
| Level | $0 |
| Description | Service Bonding Level (per contract) |
| Level | $0 |
| Description | Service Bonding Level (aggregate) |
| Level | $0 |
NAICS Codes with Size Determinations by NAICS
| Primary | Yes |
| Code | 424990 |
| NAICS Code's Description | Other Miscellaneous Nondurable Goods Merchant Wholesalers |
| Buy Green | Yes |
| Code | 339113 |
| NAICS Code's Description | Surgical Appliance and Supplies Manufacturing |
| Buy Green | Yes |
| Code | 424210 |
| NAICS Code's Description | Drugs and Druggists’ Sundries Merchant Wholesalers |
| Buy Green | Yes |
| Code | 561910 |
| NAICS Code's Description | Packaging and Labeling Services |
| Buy Green | No |
Export Profile (Trade Mission Online)
| Exporter | No |
| Export Business Activities | (none given) |
| Exporting to | (none given) |
| Desired Export Business Relationships | (none given) |
| Description of Export Objective(s) | (none given) |
Date of last update: 15 Mar 2025
Sources: New York Secretary of State
